Repligen Corp (RGEN): who owns it and who trades it
As of Nov 16, 2026, RGEN insiders reported 13 open-market sales worth $8.2M and no purchases in the last 12 months, with 72% of the sale value made under pre-set 10b5-1 plans. The largest seller was Olivier Loeillot (CEO), with $7.7M. 6 of the 50 famous funds we follow held it at their last quarter end.
Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.
At a glance
Who is buying and selling Repligen
From the latest filingsOverall: more selling than buying. Insiders mostly sold. Famous investors mostly bought. Funds was close to even.
Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.
Who owns RGEN
475 funds and institutions reported RGEN shares worth $9B at the end of Q2 2026. Some shares are counted by more than one filer, or lent out and counted twice, so the total can pass 100%. The largest holder is BlackRock, Inc. with 9.5%.
Funds and institutions (13F) about 100%Everyone else 0%
10 largest owners, by share of the company
Top 20 owners
| Owner | Shares | % of company | Value | Change since Q1 2026 |
|---|---|---|---|---|
| BlackRock, Inc. | 5.38M | 9.55% | $735M | -10% |
| FMR LLC (Fidelity) | 3.33M | 5.90% | $454M | +15% |
| United Capital Financial Advisors, LLC | 2.79M | 4.95% | $381M | +1% |
| Vanguard Capital Management LLC | 2.41M | 4.27% | $329M | +1% |
| Vanguard Portfolio Management LLC | 2.31M | 4.10% | $316M | +0% |
| Maverick Capital Ltd | 1.98M | 3.52% | $271M | +31% |
| State Street Corp | 1.80M | 3.19% | $246M | +1% |
| T. Rowe Price Associates | 1.75M | 3.11% | $239M | -64% |
| Massachusetts Financial Services Co | 1.62M | 2.87% | $221M | +16% |
| Wasatch Advisors LP | 1.59M | 2.82% | $217M | +28% |
| Ameriprise Financial Inc | 1.58M | 2.79% | $215M | +70% |
| Bank of New York Mellon Corp | 1.52M | 2.70% | $208M | -1% |
| T. Rowe Price Investment Management, Inc. | 1.41M | 2.50% | $193M | +3% |
| Invesco Ltd. | 1.39M | 2.46% | $189M | +9% |
| Holocene Advisors, LP | 1.29M | 2.29% | $176M | +82% |
| Rtw Investments, LP | 1.24M | 2.20% | $169M | +3% |
| Geode Capital Management, LLC | 1.06M | 1.88% | $145M | -0% |
| Congress Asset Management Co | 1.01M | 1.79% | $138M | +27% |
| Conestoga Capital Advisors, LLC | 980,983 | 1.74% | $134M | -11% |
| Goldman Sachs Group Inc | 965,411 | 1.71% | $132M | +48% |
From the SEC 13F data sets: every fund manager with over $100M must report its US stock holdings every 3 months, up to 45 days after the quarter ends. Owners are shown as they file, so one group (for example Vanguard) can appear under several names. Individuals, most insiders and smaller funds do not file 13F reports.
Insider trades
In the last 12 months, RGEN insiders reported $0 of open-market purchases and $8.2M of sales. 72% of the sale value was under a 10b5-1 plan, a schedule set up in advance.
Purchases and sales by month
Latest trades
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Oct 5, 2026 | Olivier Loeillot | CEO | Sale plan | 1,333 | $178.75 | $238K | Form 4 |
| Oct 5, 2026 | Olivier Loeillot | CEO | Sale plan | 4,202 | $190.00 | $798K | Form 4 |
| Sep 24, 2026 | Olivier Loeillot | CEO | Sale plan | 8,404 | $190.00 | $1.6M | Form 4 |
| Sep 24, 2026 | Olivier Loeillot | CEO | Sale plan | 4,542 | $190.00 | $863K | Form 4 |
| Sep 21, 2026 | Olivier Loeillot | CEO | Sale plan | 5,426 | $180.00 | $977K | Form 4 |
| Sep 4, 2026 | Olivier Loeillot | CEO | Sale plan | 3,035 | $165.90 | $504K | Form 4 |
| Aug 20, 2026 | Olivier Loeillot | CEO | Sale plan | 5,426 | $180.00 | $977K | Form 4 |
| Jul 16, 2026 | Jason K Garland | CFO | Sale | 530 | $150.00 | $79.5K | Form 4 |
| Jun 25, 2026 | Jason K Garland | CFO | Sale | 733 | $145.00 | $106K | Form 4 |
| Apr 21, 2026 | Olivier Loeillot | CEO | Sale | 3,832 | $140.00 | $536K | Form 4 |
| Dec 17, 2025 | Karen A Dawes | Director | Sale | 275 | $161.00 | $44.3K | Form 4 |
| Nov 25, 2025 | Olivier Loeillot | CEO | Sale | 7,041 | $170.00 | $1.2M | Form 4 |
| Nov 18, 2025 | James Bylund | Chief Operating Officer | Sale | 2,191 | $151.21 | $331K | Form 4 |
Insiders by value traded
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| Olivier Loeillot | Chief Executive Officer, Director | – | $7.7M | Oct 5, 2026 |
| James Bylund | Chief Operating Officer | – | $331K | Nov 18, 2025 |
| Jason K Garland | CFO | – | $186K | Jul 16, 2026 |
| Karen A Dawes | Director | – | $44.3K | Dec 17, 2025 |
What this data shows, and what it doesn't
- Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
- Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
- "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
- Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
- Filings are self-reported and can be amended. Each trade links to its original filing. Methodology
RGEN short interest
High short interest. 11.0% of RGEN shares are sold short: about 1 share in 9. Over the last 12 reports the number of shares short went up 24%.
As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.
As of Oct 30, 2026, 7.05M RGEN shares were sold short, 11.0% of the shares outstanding, down 1.3% from the report before. At the average daily volume of 1.45M shares, buying them all back would take about 4.9 trading days (days to cover).
Shares short, % of all shares
Days to cover
Every report
| Settlement date | Shares short | % of shares | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|---|
| Oct 30, 2026 | 7.05M | 11.04% | -1% | 1.45M | 4.9 |
| Oct 15, 2026 | 7.15M | 12.66% | -6% | 1.46M | 4.9 |
| Sep 30, 2026 | 7.58M | 13.43% | +13% | 1.15M | 6.6 |
| Sep 15, 2026 | 6.71M | 11.89% | +2% | 947,188 | 7.1 |
| Aug 31, 2026 | 6.61M | 11.72% | +9% | 990,264 | 6.7 |
| Aug 14, 2026 | 6.09M | 10.78% | -1% | 944,670 | 6.4 |
| Jul 31, 2026 | 6.13M | 10.87% | +6% | 1.56M | 3.9 |
| Jul 15, 2026 | 5.81M | 10.30% | -4% | 732,447 | 7.9 |
| Jun 30, 2026 | 6.05M | 10.72% | +6% | 1.30M | 4.7 |
| Jun 15, 2026 | 5.73M | 10.15% | -4% | 900,271 | 6.4 |
| May 29, 2026 | 5.96M | 10.57% | +5% | 1.22M | 4.9 |
| May 15, 2026 | 5.70M | 10.10% | +4% | 1.47M | 3.9 |
Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks
Members of Congress who traded RGEN
Since Nov 17, 2024, 2 members of Congress reported 3 purchases and 4 sales of RGEN. The latest was a sale by Lisa C. McClain on Oct 31, 2025, reported Nov 21, 2025.
Purchases 3Sales 4
Reported trades
| Trade date | Member | Type | Amount | Owner | Reported | Source |
|---|---|---|---|---|---|---|
| Oct 31, 2025 | Lisa C. McClain (R-MI) | Sale | $1K–$15K | Spouse | Nov 21, 2025 | Report |
| Oct 30, 2025 | Lisa C. McClain (R-MI) | Sale | $1K–$15K | Spouse | Nov 21, 2025 | Report |
| Oct 30, 2025 | Lisa C. McClain (R-MI) | Purchase | $1K–$15K | Spouse | Nov 21, 2025 | Report |
| Jul 22, 2025 | Lisa C. McClain (R-MI) | Purchase | $1K–$15K | Spouse | Aug 13, 2025 | Report |
| Jun 17, 2025 | Lisa C. McClain (R-MI) | Partial sale | $1K–$15K | Spouse | Aug 13, 2025 | Report |
| Jun 11, 2025 | Lisa C. McClain (R-MI) | Purchase | $1K–$15K | Spouse | Aug 13, 2025 | Report |
| Apr 7, 2025 | Jefferson Shreve (R-IN) | Sale | $15K–$50K | Self | May 8, 2025 | Report |
Source: Periodic Transaction Reports filed with the Clerk of the House and the Secretary of the Senate under the STOCK Act. Members report each trade within 45 days, as a dollar range, not an exact amount. Trades by a spouse or dependent child are included and marked. Paper filings (scanned images) are not included, and Senate reports are shown for current senators only. Links to Senate reports open the Senate’s own site, which shows its terms first and can only be reached from the United States. How these reports work
Repligen company events
Repligen filed 12 reports on Form 8-K in the last 12 months, 2 of them about an important change (leadership). The latest was on Nov 6, 2026.
- Nov 6, 2026AgreementIn connection with the consummation of previously announced private exchange and subscription transactions, Repligen Corporation issued $1.0 billion of its 0.25% Convertible Senior Notes due 2031 under an Indenture, dated November 6, 2026, between the Company and U.S. Bank Trust Company, National… Filing
- Oct 30, 2026AnnouncementOf this Current Report on Form 8-K is incorporated herein by reference. Filing
- Oct 27, 2026ResultsReleased financial results. Filing
- Oct 6, 2026DealThe information set forth in the “Explanatory Note” of this Current Report on Form 8-K is incorporated by reference into this Item 2.01. Filing
- Sep 15, 2026LeadershipKaren A. Dawes notified Repligen Corporation that she will be retiring from the Repligen Board of Directors after over twenty years of distinguished service to Repligen, effective as of September 30, 2026. Filing
- Sep 8, 2026AnnouncementAs previously disclosed, on July 21, 2026, Repligen Corporation, a Delaware corporation, entered into an Agreement and Plan of Merger with Bravo Merger Sub I, Inc., a Delaware corporation and wholly owned subsidiary of Repligen, Bravo Merger Sub II, LLC, a Delaware limited liability company and… Filing
- Jul 28, 2026ResultsReleased financial results. Filing
- Jul 22, 2026AgreementRepligen Corporation, a Delaware corporation, entered into an Agreement and Plan of Merger by and among Repligen, Bravo Merger Sub I, Inc., a Delaware corporation and wholly owned subsidiary of Repligen, Bravo Merger Sub II, LLC, a Delaware limited liability company and wholly owned subsidiary of… Filing
- May 15, 2026VoteReported shareholder vote results. Filing
- May 5, 2026ResultsReleased financial results. Filing
- Feb 24, 2026ResultsReleased financial results. Filing
- Jan 6, 2026LeadershipRepligen Corporation announced that the Board of Directors has elected Dr. Martin D. Madaus as Chair of the Board, effective March 13, 2026. Filing
From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week
Repligen financials
Famous investors that hold RGEN
6 of the 50 well-known investors we track reported holding RGEN in their latest 13F filing. The largest position is Lee Ainslie's, worth $272M.
Position size
All holders
| Fund | Quarter | Shares | Value | Of portfolio | Change |
|---|---|---|---|---|---|
| Lee Ainslie · Maverick Capital | Q3 2026 | 1.42M | $272M | 2.2% | -29% |
| Andreas Halvorsen · Viking Global Investors | Q3 2026 | 531,227 | $102M | 0.3% | New |
| Ken Griffin · Citadel Advisors | Q3 2026 | 263,824 | $50.7M | 0.0% | -30% |
| Steve Cohen · Point72 Asset Management | Q3 2026 | 241,982 | $46.5M | 0.1% | +46% |
| Ray Dalio · Bridgewater Associates | Q3 2026 | 89,106 | $17.1M | 0.1% | New |
| Stanley Druckenmiller · Duquesne Family Office | Q3 2026 | 77,400 | $14.9M | 0.4% | No change |
From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.
5%+ stakes filed in the last 120 days
Anyone who owns more than 5% of a company must report it on Schedule 13D or 13G. 2 filings named RGEN in the last 120 days.
| Filed | Holder | Form | Stake |
|---|---|---|---|
| Oct 7, 2026 | FMR LLC | 13G/A | 13.0% |
| Oct 7, 2026 | FMR LLC | 13G/A | 13.0% |
Questions about Repligen Corp (RGEN) stock
Who owns the most RGEN stock?
The largest reported owner of Repligen Corp (RGEN) is BlackRock, Inc., with 9.5% of the company. In total, 475 funds and institutions reported holding RGEN at the end of Q2 2026, together about 100% of the shares. See the largest owners.
Are RGEN insiders buying or selling?
In the last 12 months, RGEN insiders reported no open-market purchases and 13 sales worth $8.2M. The latest trade was on Oct 5, 2026. See every trade.
What is the short interest in RGEN?
As of Oct 30, 2026, 7.05M RGEN shares were sold short, 11.0% of the shares outstanding, down 1.3% from the report before. At the average daily volume of 1.45M shares, buying them all back would take about 4.9 trading days (days to cover). See the history.
Have members of Congress traded RGEN?
Yes. 2 members of Congress reported 3 purchases and 4 sales of RGEN since Nov 17, 2024. The latest was reported on Nov 21, 2025. See the trades.
Which famous investors hold RGEN?
6 of the 50 well-known investors we track reported RGEN in their latest 13F filing, including Lee Ainslie, Andreas Halvorsen, Ken Griffin. The largest position is worth $272M. See all holders.
Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.